ACADIA Pharmaceuticals Down Over 8%, on Pace for Largest Percent Decrease Since September 2025 -- Data Talk
Dow Jones2026/09/24 15:02ACADIA Pharmaceuticals Inc. (ACAD) is currently at $23.24, down $2.20 or 8.63%
--Would be lowest close since June 23, 2026, when it closed at $22.60
--On pace for largest percent decrease since Sept. 24, 2025, when it fell 9.92%
--Currently down five of the past six days
--Currently down two consecutive days; down 12.02% over this period
--Worst two day stretch since the two days ending Sept. 24, 2025, when it fell 13.33%
--Down 19.63% month-to-date; on pace for worst month since March 2024, when it fell 20.44%
--Down 13.01% year-to-date
--Down 59.24% from its all-time closing high of $57.00 on July 7, 2020
--Up 9.55% from 52 weeks ago (Sept. 25, 2025), when it closed at $21.21
--Down 23.99% from its 52-week closing high of $30.57 on Aug. 25, 2026
--Up 15.83% from its 52-week closing low of $20.06 on Oct. 13, 2025
--Traded as low as $21.97; lowest intraday level since June 22, 2026, when it hit $21.59
--Down 13.61% at today's intraday low; largest intraday percent decrease since Sept. 24, 2025, when it fell as much as 15.17%
All data as of 11:00:17 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 24, 2026 11:02 ET (15:02 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
South Korea's DRAM exports hit a record high of $33 billion in September.
QNT and NIGHT Continue to Defy Market Correction, BTC Settles After Wild Ride: Weekend Watch
Within just 40 days of its release, the split box office of iQIYI (IQ.US) "Soul Ferry" series of AI feature films exceeded 10 millions and continues to be popular.
From recouping initial investment in the first week to revenue sharing surpassing 10 million, AI unlocks the commercial value of classic IPs.
